|
|
Article: Study Suggests That Higher Loading Doses of Plavix Provides Quicker Onset of Action and Higher Levels of Platelet Inhibition.
- Article from:
- PR Newswire
- Article date:
- May 24, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
ALBION Study Shows That Higher Loading Doses Of Clopidogrel Achieved Faster and Higher Levels of Platelet Aggregation Inhibition
PARIS, May 24 /PRNewswire/ -- French investigators announced today that the results of the ALBION (Assessment of the best Loading dose of clopidogrel to Blunt platelet activation, Inflammation and Ongoing Necrosis) trial, presented at the annual EuroPCR Congress in Paris on May 24, suggest that within the first 24 hours, higher loading doses of Plavix(R) (clopidogrel) induced faster onset of action and higher levels of inhibition of platelet aggregation than the indicated loading dose of 300mg, in patients with acute coronary syndrome ...